Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06745830

Lymph Node Pathologic Grading Strategy

Lymph Node Pathologic Grading Strategy: Under the Backdrop of the IASLC Grading System for Invasive Lung Adenocarcinoma - a Retrospective Cohort Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,998 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The percentage of high-grade patterns in metastatic LNs (mLNs) that can predict poor outcomes has yet to be determined. Additionally, the potential implications of other histologic patterns in metastatic lymph nodes on patient outcomes warrant further investigation. We conducted a retrospective cohort study to investigate the prognostic value of pathologic pattern in metastatic lymph nodes.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2024-04-10
Primary completion
2024-12-30
Completion
2025-04-20
First posted
2024-12-20
Last updated
2024-12-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06745830. Inclusion in this directory is not an endorsement.

Lymph Node Pathologic Grading Strategy (NCT06745830) · Clinical Trials Directory